Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Prostate Cancer

  Free Subscription


Articles published in Prog Urol

Retrieve available abstracts of 41 articles:
HTML format
Text format



Single Articles


    February 2017
  1. LEON P, Cancel-Tassin G, Koutlidis N, Calves J, et al
    [Prevalence and diversity of management of prostate cancer patients classified as low risk using D'Amico group or Cancer of the Prostate Risk Assessment (CAPRA) score: A French multicenter study].
    Prog Urol. 2017 Feb 28. pii: S1166-7087(17)30017.
    PubMed     Text format     Abstract available


  2. CHAHWAN C, Doerfler A, Brichart N, Bouye S, et al
    Prostate cancer before renal transplantation: A multicentre study.
    Prog Urol. 2017 Feb 22. pii: S1166-7087(17)30015.
    PubMed     Text format     Abstract available


    January 2017
  3. DAUBISSE-MARLIAC L, Lamy S, Lunardi P, Tollon C, et al
    [Prostate cancer: Quality assessment of clinical management in the Midi-Pyrenean region in 2011].
    Prog Urol. 2017 Jan 20. pii: S1166-7087(16)30779.
    PubMed     Text format     Abstract available


    December 2016
  4. MORTIER P, Bastide C, Lechevallier E, Walz J, et al
    [Oncological results of active surveillance in prostate cancer: A retrospective multicentric cohort].
    Prog Urol. 2016 Dec 13. pii: S1166-7087(16)30753.
    PubMed     Text format     Abstract available


    November 2016
  5. ROZET F, Hennequin C, Beauval JB, Beuzeboc P, et al
    [CCAFU french national guidelines 2016-2018 on prostate cancer].
    Prog Urol. 2016;27 Suppl 1:S95-S143.
    PubMed     Text format     Abstract available


    September 2016
  6. MICHAUD L, Touijer KA
    [Focus on molecular imaging in prostate cancer].
    Prog Urol. 2016 Sep 20. pii: S1166-7087(16)30416.
    PubMed     Text format     Abstract available


    August 2016
  7. HOQUETIS L, Malavaud B, Game X, Beauval JB, et al
    MRI evaluation following partial HIFU therapy for localized prostate cancer: A single-center study.
    Prog Urol. 2016 Aug 24. pii: S1166-7087(16)30106.
    PubMed     Text format     Abstract available


  8. MERY B, Vallard A, Espenel S, Badie N, et al
    [Prostate cancer of elderly patients: Place and role of geriatric assessment].
    Prog Urol. 2016 Aug 24. pii: S1166-7087(16)30102.
    PubMed     Text format     Abstract available


    July 2016
  9. LORION R, Bladou F, Spatz A, van Kempen L, et al
    [Prostate cancer microenvironment: Its structure, functions and therapeutic applications].
    Prog Urol. 2016 Jul 13. pii: S1166-7087(16)30074.
    PubMed     Text format     Abstract available


    April 2016
  10. ALBISINNI S, De Groote A, Deneft F, Thoma P, et al
    [Can preoperative prostate MRI before radical prostatectomy predict extracapsular extension and the side of the index lesion?].
    Prog Urol. 2016;26:281-6.
    PubMed     Text format     Abstract available


    March 2016
  11. PLOUSSARD G, Bruyere F, Culine S, de La Taille A, et al
    [Castration modalities in prostate cancer: Are they all equal?]
    Prog Urol. 2016 Mar 23. pii: S1166-7087(16)00071.
    PubMed     Text format     Abstract available


  12. LUNARDI P, Beauval JB, Roumiguie M, Soulie M, et al
    [Mechanisms of castration resistance: Intratumoral hypoxia stimulates the androgen receptor expression].
    Prog Urol. 2016;26:159-67.
    PubMed     Text format     Abstract available


    January 2016
  13. RUFFION A, de la Taille A
    [The ambulatory is it future of radical prostatectomy? Probably not...].
    Prog Urol. 2016;26:14-5.
    PubMed     Text format    


  14. LECLERS F, Dutheil V, Poupot D, Moalic R, et al
    [Half-day case robotic radical prostatectomy. Surgery of the future? A case report].
    Prog Urol. 2016;26:10-3.
    PubMed     Text format     Abstract available


    November 2015
  15. VLAEMINCK-GUILLEM V, Devonec M, Champetier D, Decaussin-Petrucci M, et al
    Urinary PCA3 to predict prostate cancer in a cohort of 1015 patients.
    Prog Urol. 2015 Nov 13. pii: S1166-7087(15)00689.
    PubMed     Text format     Abstract available


  16. PERLBARG J, Rabetrano H, Soulie M, Salomon L, et al
    [Economic evaluation of the treatments of non-metastatic prostate cancer].
    Prog Urol. 2015;25:1108-15.
    PubMed     Text format     Abstract available


  17. SALOMON L, Ploussard G, Hennequin C, Richaud P, et al
    [Treatments around surgery of prostate cancer and surgery of recurrence].
    Prog Urol. 2015;25:1086-107.
    PubMed     Text format     Abstract available


  18. SOULIE M, Salomon L
    [Comparative oncologic and functional outcomes of prostate cancer surgery with other curative treatments].
    Prog Urol. 2015;25:1067-85.
    PubMed     Text format     Abstract available


  19. SOULIE M, Salomon L
    [Oncological outcomes of prostate cancer surgery].
    Prog Urol. 2015;25:1010-27.
    PubMed     Text format     Abstract available


  20. FROMONT G, Molinie V, Soulie M, Salomon L, et al
    [Analysis and prognostic factors of the specimen of radical prostatectomy in prostate cancer].
    Prog Urol. 2015;25:999-1009.
    PubMed     Text format     Abstract available


  21. SALOMON L, Rozet F, Soulie M
    [Surgery of prostate cancer: Technical principles and perioperative complications].
    Prog Urol. 2015;25:966-98.
    PubMed     Text format     Abstract available


  22. BEAUVAL JB, Mazerolles M, Salomon L, Soulie M, et al
    [Preoperative assessment of patient candidate to prostate cancer surgery].
    Prog Urol. 2015;25:947-65.
    PubMed     Text format     Abstract available


  23. RENARD PENNA R, Brenot-Rossi I, Salomon L, Soulie M, et al
    [Prostate cancer imaging: MRI and nuclear imaging].
    Prog Urol. 2015;25:933-46.
    PubMed     Text format     Abstract available


  24. SOULIE M, Salomon L
    [The issue of prostate cancer surgery].
    Prog Urol. 2015;25:916-7.
    PubMed     Text format    


    October 2015
  25. ROUGET B, Capon G, Bernhard JC, Robert G, et al
    [Eight years of experience with HIFU for prostate cancer: Oncological and functional results].
    Prog Urol. 2015 Oct 14. pii: S1166-7087(15)00601.
    PubMed     Text format     Abstract available


  26. BITKER MO, van Doren AS
    [Fears and tears from prostate cancer].
    Prog Urol. 2015 Oct 12. pii: S1166-7087(15)00630.
    PubMed     Text format    


  27. HENNEQUIN C, Bruyere F, Sedefdjian A, Bourouina R, et al
    [Prostate cancer treated with androgen deprivation therapy: Care and monitoring in daily practice].
    Prog Urol. 2015 Oct 8. pii: S1166-7087(15)00239.
    PubMed     Text format     Abstract available


  28. BIGOT P, Lebdai S, Azzouzi AR
    [Editorial comment to: Urinary PCA3 to predict prostate cancer in a cohort of 1015 patients].
    Prog Urol. 2015 Oct 8. pii: S1166-7087(15)00592.
    PubMed     Text format    


    September 2015
  29. ROUMIGUIE M, Beauval JB, Bordier B, Filleron T, et al
    What risk of prostate cancer led urologist to recommend prostate biopsies?
    Prog Urol. 2015 Sep 29. pii: S1166-7087(15)00242.
    PubMed     Text format     Abstract available


  30. BASSARD S, Mege JL
    [Use of MRI before biopsy in diagnosis of prostate cancer: Single-operator study].
    Prog Urol. 2015 Sep 29. pii: S1166-7087(15)00241.
    PubMed     Text format     Abstract available


  31. VLAEMINCK-GUILLEM V, Devonec M, Champetier D, Decaussi-Petrucci M, et al
    [Urinary PCA3 to predict prostate cancer in a cohort of 1015 patients].
    Prog Urol. 2015 Sep 12. pii: S1166-7087(15)00240.
    PubMed     Text format     Abstract available


    July 2015
  32. DARIANE C
    [Active surveillance for prostate cancer].
    Prog Urol. 2015 Jul 13. pii: S1166-7087(15)00201.
    PubMed     Text format     Abstract available


  33. BRENOT-ROSSI I
    [Biochemical recurrence after curative treatment for localized prostate cancer: Performance of choline PET/CT in the assessment of local recurrence].
    Prog Urol. 2015 Jul 13. pii: S1166-7087(15)00194.
    PubMed     Text format    


    June 2015
  34. GROSCLAUDE P, Belot A, Daubisse Marliac L, Remontet L, et al
    [Prostate cancer incidence and mortality trends in France from 1980 to 2011].
    Prog Urol. 2015 Jun 1. pii: S1166-7087(15)00137.
    PubMed     Text format     Abstract available


  35. ROZET F
    [A prospective trial comparing consecutive series of open retropubic and robot-assisted laparoscopic radical prostatectomy in a centre: Oncologic and functional outcomes].
    Prog Urol. 2015;25:379-80.
    PubMed     Text format    


  36. BEAUVAL JB, Roumiguie M, Ouali M, Doumerc N, et al
    [A prospective trial comparing consecutive series of open retropubic and robot-assisted laparoscopic radical prostatectomy in a centre: Oncologic and functional outcomes].
    Prog Urol. 2015;25:370-8.
    PubMed     Text format     Abstract available


  37. BALSSA L, Pastori J, Lillaz J, Panouilleres M, et al
    [Impact of obesity on pathologic outcomes and biochemical reccurence after radical prostatectomy].
    Prog Urol. 2015;25:420-7.
    PubMed     Text format     Abstract available


    March 2015
  38. RIZK J, Ouzzane A, Flamand V, Fantoni JC, et al
    [Long term biochemical recurrence free survival after radical prostatectomy for cancer: comparative analysis according to surgical approach and clinicopathological stage].
    Prog Urol. 2015;25:157-68.
    PubMed     Text format     Abstract available


    January 2015
  39. CATHELINEAU X
    [RALP: comparison of the oncological and functional outcomes of the intrafascial and the interfascial approaches].
    Prog Urol. 2015;25:62-3.
    PubMed     Text format    


  40. AL-MAMARI SA, Quintens H, Mentine N, Burte C, et al
    [RALP: comparison of the oncological and functional outcomes of the intrafascial and the interfascial approaches].
    Prog Urol. 2015;25:54-61.
    PubMed     Text format     Abstract available


    November 2014
  41. DELAGE F, Perrouin-Verbe MA, Le Fur E, Papin G, et al
    [Erectile dysfunction evaluation after brachytherapy for low risk prostate adenocarcinoma: Prospective study of patients with a baseline IIEF5>16.]
    Prog Urol. 2014 Nov 16. pii: S1166-7087(14)00624.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Prostate Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: